2018
DOI: 10.1016/j.cca.2017.12.048
|View full text |Cite
|
Sign up to set email alerts
|

Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research

Abstract: These results suggest that type 2 diabetes mellitus patients with DKD presented higher circulating MPs levels - PMPs, LMPs, EMPs, and TFMPs - which correlated with metabolic alterations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
22
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 44 publications
2
22
0
Order By: Relevance
“…In line with our results, Rodrigues et al demonstrated elevated levels of EMVs (CD51 + /AV + ) in a cohort of T2DM patients with nephropathy, 23 and EMVs (CD31 + / AV + ) were found increased in patients with microalbuminuria or macroalbuminuria, compared to those without albuminuria. 24 Furthermore, increased ratio of EMVs to EPCs was shown to be associated with reduced glomerular filtration rate (GFR), indicating that an imbalance in endothelial damage and repair capacity may in part explain reduced renal function.…”
Section: Discussionsupporting
confidence: 93%
“…In line with our results, Rodrigues et al demonstrated elevated levels of EMVs (CD51 + /AV + ) in a cohort of T2DM patients with nephropathy, 23 and EMVs (CD31 + / AV + ) were found increased in patients with microalbuminuria or macroalbuminuria, compared to those without albuminuria. 24 Furthermore, increased ratio of EMVs to EPCs was shown to be associated with reduced glomerular filtration rate (GFR), indicating that an imbalance in endothelial damage and repair capacity may in part explain reduced renal function.…”
Section: Discussionsupporting
confidence: 93%
“…Activated or apoptotic ECs, if damaged, release endothelial microparticles that we can view as circulating markers [ 42 ]. It has been demonstrated that circulating total microparticles are greatly elevated in patients with T2DM, suggesting that changing microparticle levels are possibly relevant to diabetic conditions [ 43 ], thus opening a new scenario for future investigations. Recently, it has also been demonstrated that Sterol regulatory element-binding protein 1 (SREBP1)—an important transcriptional regulator of lipogenesis [ 44 ], regulated by Sec23A [ 45 ]—is involved in the modulation of insulin resistance and in the lipogenesis that is chronically enhanced diabetes, thus laying the foundation for the development of novel future therapeutic strategies to contain the onset of diabetes.…”
Section: Endothelial Dysfunction and Diabetesmentioning
confidence: 99%
“…Circulating EVs, although to a lesser extent than uEVs, have been also investigated as biomarkers for DKD diagnosis. In this regard, increased levels of platelet-, erythrocyte-, leukocyte-, and endothelial-derived EVs have been reported in DKD patients compared to controls [ 93 , 94 , 95 ]. The role of platelet-derived EVs in GEC dysfunction was also investigated in an experimental model of streptozotocin-induced diabetes in rats by Zhang Y et al [ 96 ].…”
Section: Circulating Evs In Diabetic Kidney Diseasementioning
confidence: 99%